Expanded Access to NanoDoce

Sponsor: NanOlogy, LLC

Expanded Access
Sponsor score: 40
Inactive

ClinicalTrials ID:NCT04060628

Patient View

NanOlogy offers expanded access to NanoDoce, a sterile nanoparticulate docetaxel powder for suspension, for patients ineligible for ongoing clinical trials. This program provides an opportunity for patients to receive the investigational drug outside of standard trial criteria, ensuring broader access to potential treatment options.

Patient Parameters

Program Overview

NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Get This Program In Your Inbox

You can sign up and apply your patients for this program.